methotrexate has been researched along with Cardiovascular Stroke in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.45) | 18.7374 |
| 1990's | 2 (6.45) | 18.2507 |
| 2000's | 5 (16.13) | 29.6817 |
| 2010's | 16 (51.61) | 24.3611 |
| 2020's | 6 (19.35) | 2.80 |
| Authors | Studies |
|---|---|
| Bolster, MB; Choi, HK; Lu, N; Smith, ID; Wei, J; Zhang, Y | 1 |
| Ahmed, S; Carsons, SE; De Leon, J; Kasselman, L; Reiss, AB; Teboul, I | 1 |
| D'Andrea, E; Desai, RJ; Glynn, RJ; He, M; Kim, SC; Lee, H; Weinblatt, ME | 1 |
| Cornel, JH; Hoogeveen, RM; Stroes, ESG | 1 |
| Ayhan, A; Benkhoff, M; Dannenberg, L; Helten, C; Huhn-Wientgen, R; Ignatov, D; Kelm, M; Levkau, B; M'Pembele, R; Mourikis, P; Petzold, T; Polzin, A; Sarabhai, T; Trojovsky, K; Zako, S; Zeus, T | 1 |
| Chen, J; Cooper, D; Norling, LV | 1 |
| de Lima, AD; Guido, MC; Kalil-Filho, R; Maranhão, RC; Marques, AF; Nicolau, JC; Salemi, VM; Tavares de Melo, MD; Tavares, ER | 1 |
| Couzin-Frankel, J | 1 |
| Bertrand, O; Butman, S; Clearfield, M; Everett, BM; Glynn, RJ; Goldhaber, SZ; Gupta, M; Hasan, A; Iturriaga, E; Johnston, J; Le May, M; Libby, P; MacFadyen, JG; Mam, V; Ofori, C; Paynter, NP; Pradhan, A; Ridker, PM; Rosenberg, Y; Saklayen, M; Seagle, R; Singh, N; Solomon, DH; Tsigoulis, M; Verma, S; Zaharris, E | 1 |
| Ridker, PM | 1 |
| Goyal, M; Pandey, A | 1 |
| Flores, RM; Kanth, R; Shah, MS | 1 |
| Chen, L; Curtis, JR; Graham, DJ; Griffin, MR; Harrold, LR; Herrinton, LJ; Kowal, MK; Kuriya, B; Lewis, JD; Lii, J; Liu, L; Rassen, JA; Saag, KG; Solomon, DH | 1 |
| Clearfield, M; Everett, BM; Glynn, RJ; Gupta, M; Hasan, AA; Libby, P; Macfadyen, J; Paynter, N; Pradhan, AD; Ridker, PM; Solomon, DH; Zaharris, E | 1 |
| da Silva, RL; Fattah, T; Lueneberg, ME; Mascia Gottschall, CA; Moreira, DM | 1 |
| Ahlehoff, O; Bryld, LE; Gislason, G; Gniadecki, R; Hansen, PR; Iversen, L; Kristensen, SL; Lasthein, S; Lindhardsen, J; Skov, L; Torp-Pedersen, C | 1 |
| Al-Mutairi, N; Bachelez, H; Gulliver, S; Gulliver, WP; Randell, S; Young, HM | 1 |
| Deleuran, MS; Hjuler, KF; Iversen, L; Jakobsen, L; Olsen, M; Riis, JL; Vestergaard, C | 1 |
| Al-Mutairi, N; Shaaban, D | 1 |
| Cloutier, M; Dea, K; Guérin, A; Mulani, P; Sundaram, M; Wu, JJ | 1 |
| Hobbs, R; Tan, CD; Zardkoohi, O | 1 |
| Ahlehoff, O; Gislason, G; Hansen, PR; Lindhardsen, J; Skov, L | 1 |
| ACQUARELLI, MJ; FEDER, RJ; GORDON, HE | 1 |
| Asakura, M; Asanuma, H; Hori, M; Kitakaze, M; Minamino, T; Mori, H; Node, K; Ogai, A; Ogita, H; Sanada, S; Shinozaki, Y; Takashima, S; Tomoike, H | 1 |
| Krishnan, E; Lingala, VB; Singh, G | 1 |
| Choudhry, VP; Dixit, A; Kannan, M; Mahapatra, M; Saxena, R | 1 |
| Bernatsky, S; Hudson, M; Suissa, S | 1 |
| Huikuri, HV; Kettunen, R; Oikarinen, A; Takkunen, JT | 1 |
| Neuhaus, KL; Zeymer, U | 1 |
| Sahn, SA | 1 |
2 review(s) available for methotrexate and Cardiovascular Stroke
| Article | Year |
|---|---|
Cardiac Dysfunction in Rheumatoid Arthritis: The Role of Inflammation.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Atherosclerosis; Etanercept; Heart Failure; Humans; Hydroxychloroquine; Inflammation; Methotrexate; Myocardial Infarction; Myocardial Ischemia; Risk Factors; Stroke Volume; Sulfasalazine | 2021 |
Immunologic diseases of the pleura.
Topics: Adult; Aged; Bromocriptine; Cardiac Surgical Procedures; Collagen Diseases; Dantrolene; Female; Granulomatosis with Polyangiitis; Heart Injuries; Humans; Immune System Diseases; Immunoblastic Lymphadenopathy; Lupus Erythematosus, Systemic; Male; Methotrexate; Methysergide; Middle Aged; Myocardial Infarction; Nitrofurantoin; Pacemaker, Artificial; Pleural Diseases; Pleural Effusion; Practolol; Procarbazine; Rheumatic Diseases; Sarcoidosis; Syndrome; Thoracic Injuries | 1985 |
4 trial(s) available for methotrexate and Cardiovascular Stroke
| Article | Year |
|---|---|
Methotrexate effects on adenosine receptor expression in peripheral monocytes of persons with type 2 diabetes and cardiovascular disease.
Topics: Adenosine; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Gene Expression; Humans; Inflammation; Leukocytes, Mononuclear; Methotrexate; Monocytes; Myocardial Infarction; Receptors, Purinergic P1 | 2022 |
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
Topics: Aged; Atherosclerosis; C-Reactive Protein; Cardiovascular Diseases; Confidence Intervals; Coronary Artery Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Interleukin-1beta; Interleukin-6; Male; Metabolic Syndrome; Methotrexate; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Statistics, Nonparametric; Stroke; Transaminases | 2019 |
Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis.
Topics: Algorithms; Anti-Inflammatory Agents; Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Inflammation; Metabolic Syndrome; Methotrexate; Myocardial Infarction; Research Design | 2013 |
Rationale and design of the TETHYS trial: the effects of methotrexate therapy on myocardial infarction with ST-segment elevation.
Topics: Adult; Aged; Area Under Curve; Blood Sedimentation; C-Reactive Protein; Cardiovascular Agents; Creatine Kinase; Creatine Kinase, MB Form; Double-Blind Method; Humans; Methotrexate; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Statistics as Topic; Treatment Outcome; Troponin; Young Adult | 2013 |
25 other study(ies) available for methotrexate and Cardiovascular Stroke
| Article | Year |
|---|---|
Alcohol consumption and the risk of mortality and myocardial infarction in patients with rheumatoid arthritis.
Topics: Alcohol Drinking; Arthritis, Rheumatoid; Cohort Studies; Humans; Methotrexate; Myocardial Infarction; Risk Factors | 2022 |
Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Heart Disease Risk Factors; Humans; Hydroxychloroquine; Medicare; Methotrexate; Myocardial Infarction; Risk Factors; United States | 2022 |
[Anti-inflammatory therapy in cardiovascular disease; from hypothesis to future guideline?]
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Cardiovascular Diseases; Colchicine; Humans; Inflammation; Methotrexate; Myocardial Infarction; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Translational Research, Biomedical | 2020 |
MTX Treatment Does Not Improve Outcome in Mice with AMI.
Topics: Animals; Blood Cell Count; Blood Platelets; Disease Models, Animal; Male; Methotrexate; Mice, Inbred C57BL; Myocardial Infarction; Serum Amyloid P-Component; Systole; Treatment Outcome; Ventricular Function, Left | 2021 |
Methotrexate carried in lipid core nanoparticles reduces myocardial infarction size and improves cardiac function in rats.
Topics: Animals; Apoptosis; Coronary Vessels; Lipids; Male; Methotrexate; Myocardial Infarction; Myocardium; Nanoparticles; Necrosis; Rats, Wistar; Vascular Endothelial Growth Factor A; Ventricular Function, Left; Ventricular Remodeling | 2017 |
Anti-inflammatory prevents heart attacks.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Clinical Trials as Topic; Humans; Infusions, Intravenous; Interleukin-1beta; Methotrexate; Myocardial Infarction | 2017 |
Methotrexate for Prevention of Cardiovascular Events. Reply.
Topics: Cardiovascular Diseases; Humans; Methotrexate; Myocardial Infarction | 2019 |
Methotrexate: CIRTified for preventing atherosclerotic events?
Topics: Antirheumatic Agents; Atherosclerosis; Hospitalization; Humans; Methotrexate; Myocardial Infarction; Stroke | 2019 |
Statin-associated polymyositis following omeprazole treatment.
Topics: Anticholesteremic Agents; Atorvastatin; Drug Interactions; Esophagitis; Gemfibrozil; Heptanoic Acids; Humans; Male; Methotrexate; Middle Aged; Myocardial Infarction; Omeprazole; Polymyositis; Prednisone; Proton Pump Inhibitors; Pyrroles; Treatment Outcome; Withholding Treatment | 2013 |
Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Cohort Studies; Female; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Proportional Hazards Models; Retrospective Studies; Risk; Stroke; Treatment Outcome; Tumor Necrosis Factor-alpha | 2013 |
Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort.
Topics: Adult; Aged; Anti-Inflammatory Agents; Biological Products; Cardiovascular Diseases; Cause of Death; Climatotherapy; Cyclosporine; Denmark; Dermatologic Agents; Female; Follow-Up Studies; Humans; Incidence; Longitudinal Studies; Male; Methotrexate; Middle Aged; Myocardial Infarction; Phototherapy; Psoriasis; Registries; Retinoids; Severity of Illness Index; Stroke; Tumor Necrosis Factor-alpha; Ustekinumab | 2015 |
Psoriasis Patients Treated With Biologics and Methotrexate Have a Reduced Rate of Myocardial Infarction: A Collaborative Analysis Using International Cohorts.
Topics: Administration, Cutaneous; Administration, Oral; Biological Products; Canada; Cohort Studies; Comorbidity; Denmark; Dermatologic Agents; Humans; Incidence; Internationality; Kuwait; Methotrexate; Myocardial Infarction; Protective Factors; Psoriasis; Severity of Illness Index; Ultraviolet Therapy; United States | 2016 |
Hospital-diagnosed atopic dermatitis and long-term risk of myocardial infarction: a population-based follow-up study.
Topics: Adult; Aged; Ambulatory Care; Azathioprine; Case-Control Studies; Cyclosporine; Denmark; Dermatitis, Atopic; Eczema; Female; Follow-Up Studies; Hospitalization; Hospitals; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Myocardial Infarction; Registries; Risk Factors; Young Adult | 2016 |
The effect of tumor necrosis factor inhibitor therapy on the incidence of myocardial infarction in patients with psoriasis: a retrospective study.
Topics: Adalimumab; Administration, Topical; Adult; Dermatologic Agents; Drug Therapy, Combination; Etanercept; Female; Humans; Incidence; Infliximab; Male; Methotrexate; Middle Aged; Myocardial Infarction; Psoriasis; Retrospective Studies; Risk; Tumor Necrosis Factor-alpha | 2018 |
Cardiovascular event risk assessment in psoriasis patients treated with tumor necrosis factor-α inhibitors versus methotrexate.
Topics: Adalimumab; Adolescent; Adult; Aged; Angina, Unstable; Cardiovascular Diseases; Dermatologic Agents; Etanercept; Female; Humans; Infliximab; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Protective Factors; Psoriasis; Risk Assessment; Stroke; Time Factors; Tumor Necrosis Factor-alpha; Young Adult | 2017 |
A rare shock.
Topics: Aged; Anti-Inflammatory Agents; Biopsy; Cardiac Catheterization; Churg-Strauss Syndrome; Coronary Angiography; Coronary Care Units; Diagnosis, Differential; Diuretics; Drug Therapy, Combination; Echocardiography; Electrocardiography; Endocardium; Eosinophilia; Female; Furosemide; Hemodynamics; Humans; Immunosuppressive Agents; Infusions, Intravenous; Methotrexate; Methylprednisolone; Myocardial Infarction; Myocardium; Nitroprusside; Prednisone; Shock, Cardiogenic; Vasodilator Agents | 2011 |
[Patients with psoriasis have an increased risk of cardiovascular diseases].
Topics: Antirheumatic Agents; Atrial Fibrillation; Cardiovascular Diseases; Denmark; Humans; Immunosuppressive Agents; Methotrexate; Myocardial Infarction; Practice Guidelines as Topic; Psoriasis; Risk Factors; Venous Thromboembolism | 2012 |
COMPLICATIONS INHERENT IN CONTINUOUS INTRA-ARTERIAL CHEMOTHERAPY OF HEAD AND NECK CARCINOMA.
Topics: Carcinoma, Squamous Cell; Cerebrovascular Disorders; Embolism, Air; Head; Head and Neck Neoplasms; Humans; Infusions, Parenteral; Methotrexate; Myocardial Infarction; Neoplasms; Pneumonia; Pulmonary Atelectasis; Pulmonary Embolism; Sepsis; Squamous Cell Carcinoma of Head and Neck; Thrombophlebitis | 1964 |
Methotrexate and MX-68, a new derivative of methotrexate, limit infarct size via adenosine-dependent mechanisms in canine hearts.
Topics: 2-Aminoadipic Acid; Adenosine; Animals; Cardiotonic Agents; Dogs; Methotrexate; Myocardial Infarction; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Theophylline | 2004 |
Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Case Management; Cohort Studies; Female; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Mortality; Myocardial Infarction; North America; Outcome Assessment, Health Care; Prednisone; Prospective Studies; Regression Analysis; Risk | 2004 |
Roles of protein C, protein S, and antithrombin III in acute leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Asparaginase; Cyclophosphamide; Cytarabine; Disseminated Intravascular Coagulation; Female; Humans; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Methotrexate; Myocardial Infarction; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Prednisone; Protein C; Protein S; Thrombosis; Vincristine | 2006 |
Antirheumatic drug use and the risk of acute myocardial infarction.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Case-Control Studies; Cohort Studies; Female; Humans; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Myocardial Infarction; Random Allocation; Treatment Outcome | 2006 |
Heart risks of RA drugs compared. Biologics confer same risk as old-fashioned methotrexate; cytotoxic drugs increase cardiac risk.
Topics: Arthritis, Rheumatoid; Humans; Immunosuppressive Agents; Methotrexate; Myocardial Infarction; Stroke | 2007 |
Methotrexate-linked ventricular arrhythmias.
Topics: Administration, Oral; Adult; Angina Pectoris; Arrhythmias, Cardiac; Biopsy; Coronary Angiography; Dermatologic Agents; Electrocardiography, Ambulatory; Endocardium; Heart Arrest; Humans; Male; Methotrexate; Myocardial Infarction; Psoriasis; Recurrence; Ventricular Premature Complexes | 1995 |
[Acute coronary thrombosis and myocardial ischemia following chemotherapy of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Coronary Disease; Coronary Thrombosis; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Male; Methotrexate; Myocardial Infarction; Neoplasm Recurrence, Local | 1990 |